| Literature DB >> 26918091 |
Pietro Cignini1, Lucia Mangiafico1, Francesco Padula1, Laura D'Emidio1, Nella Dugo1, Alessia Aloisi2, Claudio Giorlandino1, Salvatore Giovanni Vitale3.
Abstract
During pregnancy, iron deficiency anemia is recognized as a specific risk factor for both adverse maternal and perinatal outcome. We decided to test the hypothesis that the daily administration of Lafergin(®), a dietary multicomponent based on Ferrazone(®) (Ferric Sodium EDTA), Lactoferrin, Vitamin C and Vitamin B12, from first trimester of pregnancy until the end of gestation, may significantly reduce, in anemic women, the severity of anemia compared to controls who received ferrous sulfate or liposomal iron.Entities:
Keywords: anemia; birth wight; iron supplementation; pregnancy
Year: 2015 PMID: 26918091 PMCID: PMC4747564 DOI: 10.11138/jpm/2015.9.1.001
Source DB: PubMed Journal: J Prenat Med ISSN: 1971-3282